Overview Escalating Dose Study in Healthy Volunteers With SEN0014196 Status: Completed Trial end date: 2010-05-01 Target enrollment: Participant gender: Summary This is a trial in healthy volunteers to study the safety, tolerability and pharmacokinetics of single and multiple escalating doses of SEN0014196. Phase: Phase 1 Details Lead Sponsor: Siena Biotech S.p.A.